For provoked VTE, what is the recommended duration of DOAC therapy?

Study for the Anticoagulation and ACS Exam with tailored flashcards and multiple choice questions, each featuring hints and detailed explanations. Prepare effectively and ensure success on your exam with confidence!

Multiple Choice

For provoked VTE, what is the recommended duration of DOAC therapy?

Explanation:
Provoked VTE should be treated with a finite, time-limited course of anticoagulation because the triggering factor is temporary and the risk of recurrence drops once it resolves. Three months of DOAC therapy is the standard duration in this setting, balancing effectiveness with bleeding risk. Extending therapy beyond three months is typically not needed unless there are persistent risk factors or the VTE is unprovoked. Shorter than three months is usually insufficient to treat the clot, while longer durations are more appropriate for unprovoked VTE or cancer-associated cases. So, three months of DOAC therapy best fits provoked VTE.

Provoked VTE should be treated with a finite, time-limited course of anticoagulation because the triggering factor is temporary and the risk of recurrence drops once it resolves. Three months of DOAC therapy is the standard duration in this setting, balancing effectiveness with bleeding risk. Extending therapy beyond three months is typically not needed unless there are persistent risk factors or the VTE is unprovoked. Shorter than three months is usually insufficient to treat the clot, while longer durations are more appropriate for unprovoked VTE or cancer-associated cases. So, three months of DOAC therapy best fits provoked VTE.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy